EPGL widens its 2013 sales goal from 10k units to 15k units via additional International sales channels to Asia and Europe.

Join our 3rd Q&A session for investors on Wednesday, October 17 @ 5:30PM. Investors can submit questions to: investors@epglmed.com

EPGL Team just wrapped another excellent conference call to introduce Ryan M. Stellar M.E. and discussed distribution, coding and marketing

EP Global Communications, Inc. is a new medical device company, publicly trading as ticker symbol EPGL. We look forward to updating shareholders often.

Irvine, CA · http://www.epglmed.com